- Home
- INGN vs NHS Comparison
INGN vs NHS Comparison
Compare INGN & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- NHS
- Stock Information
- Founded
- INGN 2001
- NHS 2003
- Country
- INGN United States
- NHS United States
- Employees
- INGN N/A
- NHS N/A
- Industry
- INGN Industrial Specialties
- NHS Trusts Except Educational Religious and Charitable
- Sector
- INGN Health Care
- NHS Finance
- Exchange
- INGN Nasdaq
- NHS Nasdaq
- Market Cap
- INGN 212.5M
- NHS 230.5M
- IPO Year
- INGN 2014
- NHS N/A
- Fundamental
- Price
- INGN $8.50
- NHS $7.59
- Analyst Decision
- INGN Hold
- NHS
- Analyst Count
- INGN 3
- NHS 0
- Target Price
- INGN $7.00
- NHS N/A
- AVG Volume (30 Days)
- INGN 171.0K
- NHS 111.8K
- Earning Date
- INGN 11-07-2024
- NHS 01-01-0001
- Dividend Yield
- INGN N/A
- NHS 13.44%
- EPS Growth
- INGN N/A
- NHS N/A
- EPS
- INGN N/A
- NHS N/A
- Revenue
- INGN $331,520,000.00
- NHS N/A
- Revenue This Year
- INGN $6.51
- NHS N/A
- Revenue Next Year
- INGN $4.24
- NHS N/A
- P/E Ratio
- INGN N/A
- NHS N/A
- Revenue Growth
- INGN 1.12
- NHS N/A
- 52 Week Low
- INGN $5.08
- NHS $6.95
- 52 Week High
- INGN $13.33
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- INGN 34.73
- NHS 29.68
- Support Level
- INGN $8.77
- NHS $7.74
- Resistance Level
- INGN $9.85
- NHS $7.93
- Average True Range (ATR)
- INGN 0.45
- NHS 0.08
- MACD
- INGN -0.12
- NHS -0.01
- Stochastic Oscillator
- INGN 4.30
- NHS 0.00
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.